Article
Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?
Lung cancer (Amsterdam, Netherlands) - 1 Sept 2013
Bauml Joshua, Mick Rosemarie, Zhang Yu, Watt Christopher D, Vachani Anil, Aggarwal Charu, Evans Tracey, Langer Corey
Abstract excerpt
INTRODUCTION: Mutations in EGFR and KRAS can impact treatment decisions for patients with NSCLC. The incidence of these mutations varies, and it is unclear whether there is a decreased frequency among African Americans (AfAs). METHODS: We performed a retrospective chart review of 513 NSCLC patients undergoing EGFR and KRAS mutational analysis at the Hospital of the University of Pennsylvania between May 2008 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
